<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-139206" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Parry-Romberg Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Shalin S.</given-names>
          </name>
          <aff>S N Eye Hospital, Vadodara</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chhabra</surname>
            <given-names>Mohit</given-names>
          </name>
          <aff>University of Delhi</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shalin Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohit Chhabra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-139206.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Parry Romberg syndrome, or progressive hemifacial atrophy, is a progressive idiopathic disorder that presents in early childhood and spontaneously stops and remits in the teenage years. Therefore, managing cosmetic disfigurement and neurological, psychological, and ophthalmological manifestations poses a significant challenge. This activity outlines the clinical presentation, evaluation, and management of Parry Romberg syndrome and highlights the role of an interprofessional team in providing better care and rehabilitation of these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the clinical manifestations of Parry Romberg syndrome.</p></list-item><list-item><p>Determine the diagnostic approach and compare&#x000a0;systemic treatment options for Parry Romberg syndrome.</p></list-item><list-item><p>Interpret&#x000a0;the management guidelines for the ocular manifestations of Parry Romberg syndrome.</p></list-item><list-item><p>Collaborate with the interprofessional team to achieve successful cosmetic rehabilitation&#x000a0;for&#x000a0;patients with Parry Romberg syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=139206&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=139206">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-139206.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Parry Romberg syndrome (PRS), also referred to as progressive hemifacial atrophy, progressive facial hemiatrophy, or idiopathic hemifacial atrophy, was first described by C Parry and M Romberg.<xref ref-type="bibr" rid="article-139206.r1">[1]</xref>&#x000a0;It is an idiopathic, gradually progressive craniofacial asymmetry, following the atrophy of subcutaneous tissue, muscles, osseous, and cartilaginous structures. It manifests in the first 2 decades in morphologically normal-born individuals. It commonly affects&#x000a0;1 or more dermatomes&#x000a0;in the trigeminal nerve territory. It has an early onset of ophthalmic and neurological involvement and a variable maxillo-facial or cardiac involvement.</p>
      </sec>
      <sec id="article-139206.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiopathogenesis of Parry Romberg syndrome is still a topic of debate. The most commonly accepted theories are:</p>
        <list list-type="order">
          <list-item>
            <p><bold>Theory of "trophoneurosis": </bold>The earliest understanding was a dysfunction of the trophic fibers of the trigeminal and other peripheral nerves&#x02014;the complaints of chronic facial pain and trigeminal neuralgia support this theory. Confocal microscopy shows a reduction in the corneal nerve endings supplied by the ophthalmic division of the trigeminal nerve, supporting this theory.<xref ref-type="bibr" rid="article-139206.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Immune-mediated process: </bold>The widely accepted theory is that PRS is an autoimmune disorder.<xref ref-type="bibr" rid="article-139206.r3">[3]</xref>&#x000a0;Overlap with linear morphea, a form of systemic sclerosis, has been&#x000a0;commonly observed.<xref ref-type="bibr" rid="article-139206.r4">[4]</xref>&#x000a0;The presence of other autoimmune diseases like systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, ankylosing spondylitis, vitiligo, and thyroid disorders have been noted in rare cases.<xref ref-type="bibr" rid="article-139206.r5">[5]</xref>&#x000a0;The presence of anti-nuclear antibodies provides a definitive serological basis.<xref ref-type="bibr" rid="article-139206.r6">[6]</xref><xref ref-type="bibr" rid="article-139206.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Neuro-vasculitis theory:</bold> The histopathology of the cerebral lesions reveals a lymphocytic vasculitis similar to Rasmussen encephalitis.<xref ref-type="bibr" rid="article-139206.r8">[8]</xref>&#x000a0;Interstitial neurovasculitis involving the major vessels&#x000a0;explains the&#x000a0;aneurysms&#x000a0;and other cerebrovascular malformations, seen occasionally in PRS cases. Similar lesions are described along the course of the trigeminal nerve.<xref ref-type="bibr" rid="article-139206.r9">[9]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Neural crest cell disorder:&#x000a0;</bold>The presence of cerebral vascular malformations, aneurysms, and soft tissue tumors suggests a possible dysregulation of neural crest cell migration.<xref ref-type="bibr" rid="article-139206.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Sympathetic dysfunction:</bold> The superior cervical sympathetic plexus inflammation or dysfunction&#x000a0;causes ipsilateral facial atrophy, enophthalmos, and bone atrophy - similar to PRS. Ipsilateral sympathectomy shows a halt in the disease progression.<xref ref-type="bibr" rid="article-139206.r11">[11]</xref><xref ref-type="bibr" rid="article-139206.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Hereditary mechanism:</bold>&#x000a0;Wartenberg&#x000a0;described PRS as a heredo-degenerative disorder, with only a few familial cases noted to date. No specific inheritance pattern or gene has been isolated.<xref ref-type="bibr" rid="article-139206.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Trauma-induced: </bold>Online surveys of PRS patients have established a debatable association between head injury in early childhood and the onset of symptoms.<xref ref-type="bibr" rid="article-139206.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Infectious causes:</bold> Preceding infections with Varicella zoster virus, Herpes simplex virus, and <italic toggle="yes">Borrelia burgorferi</italic> have been described as risk factors.<xref ref-type="bibr" rid="article-139206.r15">[15]</xref><xref ref-type="bibr" rid="article-139206.r16">[16]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-139206.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of PRS varies from 0.3 to 2.5 cases per 100,000 population per year,&#x000a0;with a male-to-female ratio of&#x000a0;1&#x000a0;to 3.<xref ref-type="bibr" rid="article-139206.r14">[14]</xref><xref ref-type="bibr" rid="article-139206.r17">[17]</xref>&#x000a0;The onset of PRS is in the first&#x000a0;2 decades of life, with a few cases in the elderly.<xref ref-type="bibr" rid="article-139206.r18">[18]</xref>&#x000a0;The average age of diagnosis is 13.2 years, with an earlier diagnosis in the male population.<xref ref-type="bibr" rid="article-139206.r19">[19]</xref>&#x000a0;The disease shows a progressive course, followed by a "burnout" within 2&#x000a0;to 20 years and spontaneous remission.<xref ref-type="bibr" rid="article-139206.r3">[3]</xref>&#x000a0;Ophthalmic involvement occurs in up to 35% of cases.<xref ref-type="bibr" rid="article-139206.r20">[20]</xref>&#x000a0;Neurological symptoms manifest in 15 to 20%&#x000a0;of cases.<xref ref-type="bibr" rid="article-139206.r14">[14]</xref></p>
      </sec>
      <sec id="article-139206.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>PRS is predominantly an autoimmune disorder with similarities to localized scleroderma or morphea. The closest&#x000a0;mimic is linear scleroderma en coup de sabre (LSCS).<xref ref-type="bibr" rid="article-139206.r21">[21]</xref>&#x000a0;The major distinguishing feature is the absence of cicatricial alopecia and skin induration in PRS cases. In contrast, LSCS shows cutaneous sclerosis of the scalp, hyperpigmentation, and loss of scalp hair and eyebrows.</p>
      </sec>
      <sec id="article-139206.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Skin biopsy shows&#x000a0;near-complete dermal fat atrophy, minimal sclerosis, and reduced adnexal structures. The characteristic finding is a&#x000a0;diffuse pattern of dermal infiltration with lymphocyte predominance and perivascular plasma cells.<xref ref-type="bibr" rid="article-139206.r21">[21]</xref>&#x000a0;Brain biopsy, though not routinely done for PRS, shows lymphocytic interstitial vasculitis.</p>
      </sec>
      <sec id="article-139206.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical criteria favoring a diagnosis of PRS over scleroderma&#x000a0;(as proposed by Duymaz et al) are:<xref ref-type="bibr" rid="article-139206.r3">[3]</xref></p>
        <list list-type="order">
          <list-item>
            <p>Unilateral facial atrophy</p>
          </list-item>
          <list-item>
            <p>Absent&#x000a0;or minimal signs of prior inflammation or induration</p>
          </list-item>
          <list-item>
            <p>Skin atrophy with thin, soft skin and no sclerosis&#x000a0;<xref ref-type="bibr" rid="article-139206.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>The clinical symptoms and features to look out for during history taking and physical examination are:</p>
        <p>
<bold>Facial</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Facial atrophy:</bold>&#x000a0;Progressive facial asymmetry due to atrophy of the subcutaneous fat, muscles, and underlying bones ( the most common clinical finding)&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Pigmentation:</bold> Hypo- or hyperpigmented lesions over the face and ipsilateral neck</p>
          </list-item>
          <list-item>
            <p><bold>Alopecia:</bold> Involving the eyebrow and the eyelashes</p>
          </list-item>
        </list>
        <p>
<bold>Ophthalmic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Enophthalmos: </bold>Progressive enophthalmos secondary to atrophy of retrobulbar fat and the alterations in orbital anatomy due to bone atrophy</p>
          </list-item>
          <list-item>
            <p><bold>Eye-lid alterations:</bold> Pseudoptosis secondary to enophthalmos, lid retraction, lagophthalmos, eyelid atrophy, and late-onset eyelid pseudo-coloboma.<xref ref-type="bibr" rid="article-139206.r22">[22]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Orbital tumors:</bold> Orbital neurinoma&#x000a0;- an incidental finding on magnetic resonance imaging (MRI)<xref ref-type="bibr" rid="article-139206.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Extraocular muscle (EOM) changes:</bold> Thinning or fibrosis of EOM, sudden onset horizontal or vertical strabismus, nystagmus, and diplopia.</p>
          </list-item>
          <list-item>
            <p><bold>Conjunctival pigmentation:</bold>&#x000a0;Abnormal pigmentation of the palpebral conjunctiva</p>
          </list-item>
          <list-item>
            <p><bold>Scleral finding:</bold>&#x000a0;Spontaneous scleral melt&#x000a0;<xref ref-type="bibr" rid="article-139206.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Corneal manifestations:</bold> Reduced corneal sensations, reduced stromal nerve fibers on confocal microscopy, exposure to keratopathy with secondary infective keratitis, keratitc precipitates, primary endothelial failure, stromal edema, band-shaped keratopathy, and flour-like deposits in the corneal stroma.<xref ref-type="bibr" rid="article-139206.r25">[25]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Uveal changes:</bold> Acute uveitis with iritis, iridocyclitis, vitritis, panuveitis, iris atrophy, iris crystalline deposits, and Fuchs heterochromic iridocyclitis.<xref ref-type="bibr" rid="article-139206.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Lens findings:&#x000a0;</bold>Cataract and lenticular dislocation</p>
          </list-item>
          <list-item>
            <p><bold>Intra-ocular pressure (IOP) alterations:</bold>&#x000a0;Rise of IOP with acute trabeculitis or end-stage neovascular glaucoma, and ocular hypotony with iridocyclitis, ciliary body hypotrophy, or atrophy</p>
          </list-item>
          <list-item>
            <p><bold>Retinal findings:</bold> Retinal vasculitis, neuroretinitis, telangiectasia, pigment epithelial changes, retinal folds, exudative retinal detachment (RD), Coats disease, central retinal artery occlusion, chorioretinal atrophy, and retinitis pigmentosa like changes&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Involutional stage:</bold> Multiple vitreoretinal or glaucoma filtration surgeries predispose the globe to involutional changes</p>
          </list-item>
        </list>
        <p>
<bold>Neuro-ophthalmological</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Optic nerve involvement:&#x000a0;</bold>Optic neuropathy and papillitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Cranial nerve palsy:</bold> Oculomotor and trochlear nerve palsy, with restrictive strabismus</p>
          </list-item>
          <list-item>
            <p><bold>Anisocoria</bold>: Horner syndrome and tonic pupil due to autonomic disturbances</p>
          </list-item>
        </list>
        <p>
<bold>Neurologic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Epilepsy: </bold>Focal, generalized seizures or status epilepticus</p>
          </list-item>
          <list-item>
            <p><bold>Pain:</bold> Headche, trigeminal neuralgia, and facial pain</p>
          </list-item>
          <list-item>
            <p><bold>Cerebro-vascular accidents:</bold> Ischemic stroke, cerebral hemorrhage, microinfarcts, microhemorrhages, and subsequent cerebral atrophy</p>
          </list-item>
          <list-item>
            <p><bold>Vascular malformations:</bold> Aneurysms, cavernoma, hypoplastic or stenotic vessels</p>
          </list-item>
          <list-item>
            <p><bold>Movement disorders:</bold> Muscle spasms, synkinesia, pyramidal symptoms, dystonia, torticollis, and gait disturbances</p>
          </list-item>
          <list-item>
            <p><bold>Speech abnormalities:</bold> Aphasia and dysarthria&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Limb abnormalities:</bold> Limb weakness, pain, or atrophy in rare cases<xref ref-type="bibr" rid="article-139206.r14">[14]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Neuropsychiatric manifestations:</bold> Cognitive disturbances, hallucinations, and psychiatric disorders</p>
          </list-item>
        </list>
        <p>
<bold>Maxillofacial</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Bony changes:</bold> Hypoplasia of the maxilla, zygomatic bone, mandible, temporal, and rarely frontal bones</p>
          </list-item>
          <list-item>
            <p><bold>Oral manifestations:</bold> Unilateral tongue atrophy, gingival atrophy, atrophy of hard palate, and abnormal development of the teeth</p>
          </list-item>
        </list>
        <p>
<bold>Cardiac</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypertrophic cardiomyopathy and rheumatologic heart disease</p>
          </list-item>
        </list>
        <p>
<bold>Endocrine</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hashimoto thyroiditis and metabolic disorder</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-139206.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>PRS is primarily a clinical diagnosis. Various investigation modalities can be employed to rule out any overlap with similarly presenting syndromes.&#x000a0;</p>
        <p>
<bold>Ocular Evaluation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Best-corrected visual acuity, refraction, and pupillary reaction assessment</p>
          </list-item>
          <list-item>
            <p>General examination for symmetry of the face, head posture, extra-ocular muscle movements, and strabismus workup</p>
          </list-item>
          <list-item>
            <p>Orbit examination, evaluation of lid abnormalities, and ptosis workup</p>
          </list-item>
          <list-item>
            <p>Meticulous slit-lamp examination</p>
          </list-item>
          <list-item>
            <p>IOP measurement by Goldmann applanation tonometry</p>
          </list-item>
          <list-item>
            <p>Detailed fundus examination</p>
          </list-item>
          <list-item>
            <p><bold>Orbital ultrasound:</bold> In cases with media opacity due to vitritis, cataract, or corneal opacity, this modality helps diagnose the associated posterior segment pathology. Ultrasound biomicroscopy is used to look for ciliary body changes.<xref ref-type="bibr" rid="article-139206.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Orbital imaging:</bold> Orbital computed tomography (CT) scan is used to evaluate the changes in bony orbit</p>
          </list-item>
        </list>
        <p>
<bold>Neurology Evaluation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Electroencephalogram:&#x000a0;</bold>For workup of epilepsy cases, to localize the cerebral lesions</p>
          </list-item>
          <list-item>
            <p><bold>Cerebrospinal fluid (CSF) analysis:</bold>&#x000a0;CSF examination is usually found normal. The oligoclonal bands and raised IgG index are associated with T2 hyperintense lesions on MRI.<xref ref-type="bibr" rid="article-139206.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Neuro-imaging:</bold> CT scan delineates the cranial bony deformity, thinning of diploe, and intracranial calcifications. MRI T1 sequence localizes the patches of cerebral atrophy. MRI T2 sequence pinpoints the hyperintense foci in the subcortical region. MR angiogram demonstrates the extent and location of vascular malformations. Brain spectral photoemission CT (SPECT) scan can detect subclinical CNS lesions in PRS cases.<xref ref-type="bibr" rid="article-139206.r27">[27]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Rheumatology Evaluation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Anti-nuclear antibody (ANA):&#x000a0;</bold>The most commonly associated serology finding in 25 to 52% of cases.<xref ref-type="bibr" rid="article-139206.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Rheumatoid factor:</bold> Elevated titers in localized scleroderma and LSCS cases.<xref ref-type="bibr" rid="article-139206.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Other serology tests:</bold> C-reactive protein, HLA-B27 typing, extractable nuclear antigen,&#x000a0;Anti-Scl-70, Anti-cardiolipin, and Anti-dsDNA antibodies are of limited value</p>
          </list-item>
        </list>
        <p>
<bold>Dental Evaluation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>To<bold>&#x000a0;</bold>monitor progressive deformity of the jaw bones and teeth abnormalities by serial orthopantomograms and photographs.</p>
          </list-item>
        </list>
        <p>
<bold>Dermatology Evaluation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skin biopsy is not performed routinely. However, the histopathological findings help differentiate PRS from LSCS.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-139206.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The goals of management are:</p>
        <list list-type="bullet">
          <list-item>
            <p>To halt the active disease progression and induce remission</p>
          </list-item>
          <list-item>
            <p>Treatment of acute exacerbations like seizures and uveitis</p>
          </list-item>
          <list-item>
            <p>Cosmetic rehabilitation after complete remission</p>
          </list-item>
        </list>
        <p>
<bold>Medical Management</bold>
</p>
        <p>The standard management is systemic immunosuppression.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Methotrexate (MTX):&#x000a0;</bold>The preferred agent; the dose is 0.3&#x000a0;to 1 milligram/kilogram/week (mg/kg/wk). MTX is administered&#x000a0;in oral or parenteral form. Therapy is&#x000a0;continued for 12&#x000a0;to 24 months to prevent relapses.</p>
          </list-item>
          <list-item>
            <p><bold>Corticosteroids:&#x000a0;</bold>MTX is combined with oral prednisolone or intravenous methylprednisolone (IVMP).<xref ref-type="bibr" rid="article-139206.r30">[30]</xref>&#x000a0;For&#x000a0;2 months, oral prednisolone is given at a 1 mg/kg/day dose, followed by tapering doses in the third month. IVMP is administered as pulse therapy at 1000 mg/day for&#x000a0;3 days every month for&#x000a0;6 months.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Other agents:&#x000a0;</bold>Mycophenolate mofetil, cyclophosphamide, hydroxychloroquine, and cyclosporine&#x000a0;are employed&#x000a0;for resistant cases.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Psoralen and ultraviolet A (PUVA):&#x000a0;</bold>Variable efficacy in halting the disease activity.<xref ref-type="bibr" rid="article-139206.r31">[31]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Ophthalmic Management</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Acute uveitis:&#x000a0;</bold>Topical cycloplegics, topical and systemic steroids are the mainstay treatments. Acute trabeculitis is treated with topical antiglaucoma medications. Relapses are common, and aggressive management is the norm.</p>
          </list-item>
          <list-item>
            <p><bold>Keratitis:</bold>&#x000a0;Lid tapping and profuse topical lubrication are advised for exposure keratopathy. Early diagnosis and treatment of super-added infective keratitis is a must.</p>
          </list-item>
          <list-item>
            <p><bold>Corneal opacity:</bold>&#x000a0;An optical penetrating keratoplasty offers a good visual outcome for severely opacified corneas due to exposure keratopathy, infective keratitis, and primary endothelial failure.</p>
          </list-item>
          <list-item>
            <p><bold>Scleral melt:</bold> Scleral patch graft is the preferred management option.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Glaucoma:&#x000a0;</bold>Antiglaucoma medications can control the IOP in early cases. The severe cases with inadequate control of topical medications require trabeculectomy surgery.</p>
          </list-item>
          <list-item>
            <p><bold>Restrictive strabismus:</bold>&#x000a0;The small-angle deviations are corrected by the prism glasses. The large-angle strabismus cases need definitive surgical correction.</p>
          </list-item>
          <list-item>
            <p><bold>Retinal vasculitis:</bold> The&#x000a0;active disease shows vascular lesions in the mid-peripheral retina and mild vitritis. Topical and systemic immunosuppression is the primary treatment. The advanced disease shows neovascularization, vitreous hemorrhage (VH), or tractional retinal detachment (TRD). The visible nonperfused retina is lasered in cases with posterior segment neovascularization. Vitreoretinal surgery with intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is needed for cases of nonresolving VH and TRD.</p>
          </list-item>
        </list>
        <p>
<bold>Neurological Management</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Seizures: </bold>The anti-epileptic drugs are titrated as per response for long-term management.</p>
          </list-item>
          <list-item>
            <p><bold>Neuropsychiatric disorders:</bold>&#x000a0;An expert psychiatrist consultation is essential.</p>
          </list-item>
        </list>
        <p>
<bold>Rehabilitation Strategies</bold>
</p>
        <p>Cosmetic rehabilitation is attempted after at least one to&#x000a0;2 years of halt in the progression of the disease.<xref ref-type="bibr" rid="article-139206.r32">[32]</xref>&#x000a0;The commonly employed management options are:</p>
        <p>
<bold>Oculoplastic Management</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Enophthalmos:&#x000a0;</bold>Intra-orbital injection of fillers like silicone gel, hyaluronate derivates, or autologous fat graft with adipose-derived stem cells has good cosmetic results.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Ptosis:&#x000a0;</bold>Primary&#x000a0;correction of the enophthalmos often provides satisfactory cosmesis. Frontalis sling surgery is reserved for severe cases.&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Eyelid retraction:</bold> Surgically treated with levator recession or levator lengthening with relaxing myotomy technique.</p>
          </list-item>
          <list-item>
            <p><bold>Lagophthalmos:</bold> Persistent lagophthalmos requires surgical correction with permanent lateral tarsorrhaphy.</p>
          </list-item>
          <list-item>
            <p><bold>Drooping of eyebrow:</bold>&#x000a0;Browpexy or Z-plasty are good treatment options</p>
          </list-item>
          <list-item>
            <p><bold>Atrophic/Phthisis bulbi:</bold> A painless involutional globe with adequately formed conjunctival fornices requires a primary trial of the prosthetic shell. The painful phthisical eye may require enucleation surgery with a silicone implant.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Contracted socket:</bold>&#x000a0;The mucous membrane and fat grafting are needed for total surgical socket reconstruction in severe cases with forniceal shelving. A healthy socket&#x000a0;is then given a trial of the prosthetic shell.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Plastic Surgery Management</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Synthetic tissue fillers:&#x000a0;</bold>Minimally invasive modality to correct facial asymmetry. The commonly employed fillers are silicone gel, polyethylene, hydroxyapatite, and poly L-lactate.<xref ref-type="bibr" rid="article-139206.r33">[33]</xref>&#x000a0;These have excellent results in mild to moderate disease.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Autologous fat grafting:&#x000a0;</bold>The Coleman technique&#x000a0;has acceptable cosmetic outcomes for most cases.<xref ref-type="bibr" rid="article-139206.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Skeletal reconstruction:</bold>&#x000a0;Bone paste cranioplasty, bone implants, bone/cartilage grafts, and orthognathic surgery have variable success rates.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Free soft tissue transplantation:</bold> Extensively used for large-volume reconstruction. Commonly used flap sites are greater omentum, lateral thigh, parascapular muscles, latissimus dorsi muscle, and dorsal thoracic adipofascial flap. This procedure provides satisfactory cosmetic outcomes.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-139206.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The closest differential diagnosis for PRS includes the following:</p>
        <list list-type="order">
          <list-item>
            <p><bold>Rassmussen encephalitis (RE):</bold>&#x000a0;It presents with unilateral cerebral involvement and intractable seizures. Focal neurological deficits and subsequent atrophy mimic the presentation of PRS. The histopathological findings of lymphocytic vasculitis in both RE and PRS may complicate the diagnosis. PRS&#x000a0;may be associated with cases of RE, developing progressive hemifacial atrophy.<xref ref-type="bibr" rid="article-139206.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Barraquer-Simons syndrome:</bold> It is an acquired progressive lipodystrophy disorder affecting the face, neck, thorax, abdomen, and rarely the extremities. Central nervous system involvement is suggested by epilepsy and bilateral cerebral atrophy.&#x000a0;A gradual symmetric bilateral loss of subcutaneous fat tissue with renal involvement&#x000a0;helps differentiate this syndrome from PRS.<xref ref-type="bibr" rid="article-139206.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Hemifacial hypertrophy:</bold>&#x000a0;This condition shows an asymmetric enlargement of half of the face and head instead of hemiatrophy.<xref ref-type="bibr" rid="article-139206.r37">[37]</xref>&#x000a0;It is an important clinical differential for asymmetric facial deformity.</p>
          </list-item>
          <list-item>
            <p><bold>Hemifacial fat necrosis:</bold> The causes range from bulbar poliomyelitis, connective tissue diseases to trauma. The absence of muscular or osseous involvement helps differentiate these causes from PRS.<xref ref-type="bibr" rid="article-139206.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Congenital deformities:</bold> Conditions like congenital hemiatrophy or torticollis may mimic facial asymmetry caused by PRS. A careful history of onset helps differentiate these entities.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-139206.s11" sec-type="Staging">
        <title>Staging</title>
        <p>The currently used&#x000a0;classification system&#x000a0;for PRS cases is as follows:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Mild:&#x000a0;</bold>Skin and/or subcutaneous fat atrophy over a single division of the trigeminal nerve</p>
          </list-item>
          <list-item>
            <p><bold>Moderate:</bold> Skin and/or fat atrophy involving&#x000a0;2 branches of the trigeminal territory</p>
          </list-item>
          <list-item>
            <p><bold>Severe:</bold> Atrophy spread over all 3 divisions of the trigeminal nerve or any bony atrophy&#x000a0;<xref ref-type="bibr" rid="article-139206.r39">[39]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-139206.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The disease reaches the burn-out phase within 2&#x000a0;to 20 years of active disease activity. Facial asymmetry is often significant, with gross disfigurement. Ocular manifestations ranging from uveitis to keratitis to retinal pathologies require active management. Repeated attacks of uveitis or retinal vasculitis can lead to secondary glaucoma with variable visual prognosis. The neurological manifestations are often well-controlled and cause minimal disability.</p>
      </sec>
      <sec id="article-139206.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The complications that can manifest with PRS&#x000a0;are as follows:</p>
        <p>
<bold>Ophthalmic Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Corneal opacity</p>
          </list-item>
          <list-item>
            <p>Glaucoma</p>
          </list-item>
          <list-item>
            <p>Restrictive strabismus</p>
          </list-item>
          <list-item>
            <p>Retinal detachment</p>
          </list-item>
          <list-item>
            <p>Loss of vision</p>
          </list-item>
          <list-item>
            <p>Phthisis bulbi or atrophic bulbi</p>
          </list-item>
          <list-item>
            <p>Contracted socket</p>
          </list-item>
        </list>
        <p>
<bold>Neurological Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Recurrent seizure attacks and status epilepticus</p>
          </list-item>
          <list-item>
            <p>Subarachnoid hemorrhage from rupture of the cerebral aneurysms&#x000a0;<xref ref-type="bibr" rid="article-139206.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Spontaneous carotid-jugular fistula and carotid dissection due to cerebral vascular malformations</p>
          </list-item>
          <list-item>
            <p>Cerebral infarction from focal stenosis of the cerebral vasculature</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-139206.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The onset of PRS is heralded by pigmentary lesions on the neck and face, followed by progressive facial asymmetry and neurological and ocular features. Early medical-care-seeking&#x000a0;behavior among the general population can aid in early diagnosis. Adequate compliance with treatment can halt facial disfigurement. The current advances help in early and desirable cosmetic outcomes for patients.</p>
      </sec>
      <sec id="article-139206.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PRS cases may be present in the clinics of ophthalmology, neurology, or dermatology departments. These cases need multispecialty evaluation and management. Therefore, a coordinated team approach involving the neurologist, ophthalmologist, rheumatologist, dermatologist, radiologist, plastic surgeon, pharmacist, and other concerned specialties as per the patient's need is essential.&#x000a0;</p>
      </sec>
      <sec id="article-139206.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=139206&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=139206">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/parry-romberg-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=139206">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/139206/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=139206">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-139206.s17">
        <title>References</title>
        <ref id="article-139206.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolgien</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[The history of trophoneurosis with special regard to Moritz Heinrich Romberg (1795-1873) and the hemiatrophia].</article-title>
            <source>Wurzbg Medizinhist Mitt</source>
            <year>2006</year>
            <volume>25</volume>
            <fpage>175</fpage>
            <page-range>175-203</page-range>
            <pub-id pub-id-type="pmid">17333862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bucher</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fricke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cursiefen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heindl</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Trigeminal involvement in parry-romberg syndrome: an in vivo confocal microscopy study of the cornea.</article-title>
            <source>Cornea</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>e10</fpage>
            <page-range>e10-1</page-range>
            <pub-id pub-id-type="pmid">25742391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duymaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karabekmez</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Keskin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tosun</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Parry-Romberg syndrome: facial atrophy and its relationship with other regions of the body.</article-title>
            <source>Ann Plast Surg</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>457</fpage>
            <page-range>457-61</page-range>
            <pub-id pub-id-type="pmid">19745718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bucher</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fricke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Neugebauer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cursiefen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heindl</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmological manifestations of Parry-Romberg syndrome.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2016</year>
            <season>Nov-Dec</season>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>693</fpage>
            <page-range>693-701</page-range>
            <pub-id pub-id-type="pmid">27045226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia-de la Torre</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Castello-Sendra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Esgleyes-Ribot</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Martinez-Bonilla</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guerrerosantos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fritzler</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies in Parry-Romberg syndrome: a serologic study of 14 patients.</article-title>
            <source>J Rheumatol</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-7</page-range>
            <pub-id pub-id-type="pmid">7699686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonul</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dogan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Izci</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Varol</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Parry-Romberg syndrome in association with anti-dsDNA antibodies: a case report.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>740</fpage>
            <page-range>740-2</page-range>
            <pub-id pub-id-type="pmid">16268883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poniecki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bernacka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hryszko</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Romberg-type hemiatrophy in a case of severe rheumatoid arthritis].</article-title>
            <source>Wiad Lek</source>
            <year>1971</year>
            <month>Jul</month>
            <day>01</day>
            <volume>24</volume>
            <issue>13</issue>
            <fpage>1313</fpage>
            <page-range>1313-5</page-range>
            <pub-id pub-id-type="pmid">5094453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Juh&#x000e1;sz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kupsky</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Asano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sood</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fain</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chugani</surname>
                <given-names>HT</given-names>
              </name>
            </person-group>
            <article-title>Rasmussen encephalitis associated with Parry-Romberg syndrome.</article-title>
            <source>Neurology</source>
            <year>2003</year>
            <month>Aug</month>
            <day>12</day>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>395</fpage>
            <page-range>395-7</page-range>
            <pub-id pub-id-type="pmid">12913207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuechler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaliaperumal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fanning</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wyse</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Aneurysmal subarachnoid haemorrhage in Parry-Rhomberg syndrome.</article-title>
            <source>BMJ Case Rep</source>
            <year>2011</year>
            <month>Nov</month>
            <day>15</day>
            <volume>2011</volume>
            <pub-id pub-id-type="pmid">22674607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pichiecchio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uggetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grazia Egitto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zappoli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Parry-Romberg syndrome with migraine and intracranial aneurysm.</article-title>
            <source>Neurology</source>
            <year>2002</year>
            <month>Aug</month>
            <day>27</day>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>606</fpage>
            <page-range>606-8; discussion 481</page-range>
            <pub-id pub-id-type="pmid">12196658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cory</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Clayman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Faillace</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Gama</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome).</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>751</fpage>
            <page-range>751-7</page-range>
            <pub-id pub-id-type="pmid">9127045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Kehdy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abbas</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rubeiz</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A review of Parry-Romberg syndrome.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>769</fpage>
            <page-range>769-84</page-range>
            <pub-id pub-id-type="pmid">22405645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Progressive hemifacial atrophy. A natural history study.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1995</year>
            <volume>93</volume>
            <fpage>203</fpage>
            <page-range>203-15; discussion 215-7</page-range>
            <pub-id pub-id-type="pmid">8719679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Parry-Romberg syndrome: a global survey of 205 patients using the Internet.</article-title>
            <source>Neurology</source>
            <year>2003</year>
            <month>Sep</month>
            <day>09</day>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>674</fpage>
            <page-range>674-6</page-range>
            <pub-id pub-id-type="pmid">12963760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fea</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Aragno</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Briamonte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Franzone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Putignano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grignolo</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Parry Romberg syndrome with a wide range of ocular manifestations: a case report.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2015</year>
            <month>Sep</month>
            <day>05</day>
            <volume>15</volume>
            <fpage>119</fpage>
            <pub-id pub-id-type="pmid">26340917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahin</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Bari&#x0015f;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karaman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Parry-Romberg syndrome: a possible association with borreliosis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-7</page-range>
            <pub-id pub-id-type="pmid">15009307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peterson</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>O'Fallon</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.</article-title>
            <source>J Rheumatol</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-80</page-range>
            <pub-id pub-id-type="pmid">9002014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendonca</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Viana</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Freitas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Late-onset progressive facial hemiatrophy (Parry-Romberg syndrome).</article-title>
            <source>J Postgrad Med</source>
            <year>2005</year>
            <season>Apr-Jun</season>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-6</page-range>
            <pub-id pub-id-type="pmid">16006711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vix</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mathis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lacoste</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guillevin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Neau</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Neurological Manifestations in Parry-Romberg Syndrome: 2 Case Reports.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>94</volume>
            <issue>28</issue>
            <fpage>e1147</fpage>
            <pub-id pub-id-type="pmid">26181554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tiwari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Khera</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sureka</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Budania</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Parry Romberg syndrome: Imaging features in 4 consecutive cases and review of literature.</article-title>
            <source>J Clin Neurosci</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>76</volume>
            <fpage>249</fpage>
            <page-range>249-253</page-range>
            <pub-id pub-id-type="pmid">32317188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orozco-Covarrubias</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guzm&#x000e1;n-Meza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ridaura-Sanz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carrasco Daza</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sosa-de-Martinez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ruiz-Maldonado</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them?</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>361</fpage>
            <page-range>361-6</page-range>
            <pub-id pub-id-type="pmid">12224693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guberina</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Coloboma in progressive hemifacial atrophy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1977</year>
            <month>Jul</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-9</page-range>
            <pub-id pub-id-type="pmid">900223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derex</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Isnard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Revol</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Progressive facial hemiatrophy with multiple benign tumors and hamartomas.</article-title>
            <source>Neuropediatrics</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>306</fpage>
            <page-range>306-9</page-range>
            <pub-id pub-id-type="pmid">8719745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoang-Xuan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jakobiec</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Tauber</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sainz de la Maza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krebs</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Romberg's progressive hemifacial atrophy: an association with scleral melting.</article-title>
            <source>Cornea</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>361</fpage>
            <page-range>361-6</page-range>
            <pub-id pub-id-type="pmid">1889224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moloney</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shojania</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Corneal findings in Parry-Romberg syndrome.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>e2</fpage>
            <page-range>e2-5</page-range>
            <pub-id pub-id-type="pmid">24513374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>La Hey</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baarsma</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Fuchs' heterochromic cyclitis and retinal vascular abnormalities in progressive hemifacial atrophy.</article-title>
            <source>Eye (Lond)</source>
            <year>1993</year>
            <volume>7 ( Pt 3)</volume>
            <fpage>426</fpage>
            <page-range>426-8</page-range>
            <pub-id pub-id-type="pmid">8224299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grosso</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fioravanti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biasi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Conversano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marcolongo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Morgese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Balestri</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Linear scleroderma associated with progressive brain atrophy.</article-title>
            <source>Brain Dev</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-61</page-range>
            <pub-id pub-id-type="pmid">12536035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sommer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gambichler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bacharach-Buhles</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>von Rothenburg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Altmeyer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kreuter</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-33</page-range>
            <pub-id pub-id-type="pmid">16443052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zulian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Athreya</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Laxer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Feitosa de Oliveira</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Punaro</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Cuttica</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Van Suijlekom-Smit</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Lindsley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcia-Consuegra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Esteves Hil&#x000e1;rio</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Lepore</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garay</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Uziel</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Foeldvari</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Peserico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>J</given-names>
              </name>
              <collab>Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES)</collab>
            </person-group>
            <article-title>Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2006</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>614</fpage>
            <page-range>614-20</page-range>
            <pub-id pub-id-type="pmid">16368732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreuter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gambichler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Breuckmann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rotterdam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Freitag</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stuecker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Altmeyer</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma.</article-title>
            <source>Arch Dermatol</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>141</volume>
            <issue>7</issue>
            <fpage>847</fpage>
            <page-range>847-52</page-range>
            <pub-id pub-id-type="pmid">16027298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gambichler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kreuter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rotterdam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Altmeyer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Linear scleroderma 'en coup de sabre' treated with topical calcipotriol and cream psoralen plus ultraviolet A.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>601</fpage>
            <page-range>601-2</page-range>
            <pub-id pub-id-type="pmid">12941109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schultz</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Truong</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Maricevich</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Parry Romberg Syndrome.</article-title>
            <source>Clin Plast Surg</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>231</fpage>
            <page-range>231-237</page-range>
            <pub-id pub-id-type="pmid">30851754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortega</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Sastoque</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>New and Successful Technique for the Management of Parry-Romberg Syndrome's Soft Tissue Atrophy.</article-title>
            <source>J Craniofac Surg</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>e507</fpage>
            <page-range>e507-10</page-range>
            <pub-id pub-id-type="pmid">26335318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Katzel</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Fat Grafting for Facial Filling and Regeneration.</article-title>
            <source>Clin Plast Surg</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>289</fpage>
            <page-range>289-300, vii</page-range>
            <pub-id pub-id-type="pmid">26116934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Echenne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>S&#x000e9;bire</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Parry Romberg syndrome and linear scleroderma en coup de sabre mimicking Rasmussen encephalitis.</article-title>
            <source>Neurology</source>
            <year>2007</year>
            <month>Dec</month>
            <day>11</day>
            <volume>69</volume>
            <issue>24</issue>
            <fpage>2274; author reply 2274</fpage>
            <pub-id pub-id-type="pmid">18071151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simsek-Kiper</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Roach</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Utine</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Boduroglu</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Barraquer-Simons syndrome: a rare clinical entity.</article-title>
            <source>Am J Med Genet A</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>164A</volume>
            <issue>7</issue>
            <fpage>1756</fpage>
            <page-range>1756-60</page-range>
            <pub-id pub-id-type="pmid">24788242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GORLIN</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>MESKIN</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Congenital hemihypertrophy. Review of the literature and report of a case with special emphasis on oral manifestations.</article-title>
            <source>J Pediatr</source>
            <year>1962</year>
            <month>Dec</month>
            <volume>61</volume>
            <fpage>870</fpage>
            <page-range>870-9</page-range>
            <pub-id pub-id-type="pmid">13949299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antoniades</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Giannouli</surname>
                <given-names>Th</given-names>
              </name>
              <name>
                <surname>Vahtsevanos</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hemifacial atrophy secondary to poliomyelitis.</article-title>
            <source>Int J Oral Maxillofac Surg</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>215</fpage>
            <page-range>215-6</page-range>
            <pub-id pub-id-type="pmid">9180234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-139206.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaienti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Soresina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Menozzi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Parascapular free flap and fat grafts: combined surgical methods in morphological restoration of hemifacial progressive atrophy.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>699</fpage>
            <page-range>699-711</page-range>
            <pub-id pub-id-type="pmid">16141804</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
